21.07.2011 • NewsAkzoNobelQ2 2011sales and profits

AkzoNobel Q2 Profit Flat

AkzoNobel reported that its second-quarter profit from continuing operations was almost flat at €273 million. Earnings per share from continuing operations were €1.07 compared to €1.05 in the previous year quarter.

Net income for the period was €268 million, lower than €273 million in the prior year quarter. Earnings per share from total operations decreased to €1.14 from €1.16 in the same quarter last year.

Adjusted net income for continuing operations was €256 million, compared to €275 million in the same period last year. Adjusted earnings per share for the quarter were 1.09, down from €1.18 in the previous year quarter.

Quarterly revenue rose 5% to €4.1 billion from €3.91 billion last year, driven by volume and price.

Looking ahead, Akzo Nobel expects full-year EBITDA to be at least in line with the prior year, assuming no further deterioration in economic conditions.

 

Company

Akzo Nobel GmbH

Kreuzauer Str. 46
52355 Düren
Germany

Company contact







Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.